Rigel Pharmaceuticals (RIGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 179,278 | 116,882 | 120,242 | 149,236 | 108,621 |
| Cost of Goods | 18,647 | 7,110 | 1,749 | 1,083 | 895 |
| Gross Profit | 160,631 | 109,772 | 118,493 | 148,153 | 107,726 |
| Operating Expenses | 137,086 | 130,373 | 174,792 | 160,732 | 137,594 |
| Operating Income | 24,192 | -20,491 | -55,550 | -12,496 | -28,973 |
| Interest Expense | 7,918 | 6,872 | 3,707 | 4,860 | 1,353 |
| Other Income | 2,092 | 2,272 | 684 | 47 | 582 |
| Pre-tax Income | 18,366 | -25,091 | -58,573 | -17,309 | -29,744 |
| Income Tax | 881 | N/A | N/A | 605 | N/A |
| Net Income Continuous | 17,485 | -25,091 | -58,573 | -17,914 | -29,744 |
| Net Income | $17,485 | $-25,091 | $-58,573 | $-17,914 | $-29,744 |
| EPS Basic Total Ops | 0.99 | -1.44 | -3.44 | -1.10 | -1.80 |
| EPS Basic Continuous Ops | 0.99 | -1.44 | -3.44 | -1.05 | -1.76 |
| EPS Diluted Total Ops | 0.99 | -1.44 | -3.44 | -1.10 | -1.80 |
| EPS Diluted Continuous Ops | 0.99 | -1.44 | -3.44 | -1.05 | -1.76 |
| EPS Diluted Before Non-Recurring Items | 0.99 | -1.40 | -3.40 | -1.10 | -1.80 |
| EBITDA(a) | $25,711 | $-19,732 | $-54,615 | $-11,047 | $-28,389 |